214 related articles for article (PubMed ID: 32165122)
1. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Pavan E; Peruzzo P; Cattarossi S; Bergamin N; Bordugo A; Sechi A; Scarpa M; Biasizzo J; Colucci F; Dardis A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928321
[TBL] [Abstract][Full Text] [Related]
3. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C.
Ries M; Schaefer E; Lührs T; Mani L; Kuhn J; Vanier MT; Krummenauer F; Gal A; Beck M; Mengel E
J Inherit Metab Dis; 2006 Oct; 29(5):647-52. PubMed ID: 16972172
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease paradigm: from ERAD to comorbidity.
Bendikov-Bar I; Horowitz M
Hum Mutat; 2012 Oct; 33(10):1398-407. PubMed ID: 22623374
[TBL] [Abstract][Full Text] [Related]
5. The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase.
Fog CK; Zago P; Malini E; Solanko LM; Peruzzo P; Bornaes C; Magnoni R; Mehmedbasic A; Petersen NHT; Bembi B; Aerts JFMG; Dardis A; Kirkegaard T
EBioMedicine; 2018 Dec; 38():142-153. PubMed ID: 30497978
[TBL] [Abstract][Full Text] [Related]
6. Adult Gaucher disease in southern Tunisia: report of three cases.
Ben Rhouma F; Kallel F; Kefi R; Cherif W; Nagara M; Azaiez H; Jedidi I; Elloumi M; Abdelhak S; Mseddi S
Diagn Pathol; 2012 Jan; 7():4. PubMed ID: 22233685
[TBL] [Abstract][Full Text] [Related]
7. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
[TBL] [Abstract][Full Text] [Related]
8. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.
Ron I; Rapaport D; Horowitz M
Hum Mol Genet; 2010 Oct; 19(19):3771-81. PubMed ID: 20643691
[TBL] [Abstract][Full Text] [Related]
9. [Gaucher disease--one of the possible causes of splenomegaly--case report].
Sokołowska B; Skomra D; Czartoryska B; Tomczak W; Tylki-Szymańska A; Repelewska M; Drop A; Gromek T
Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093
[TBL] [Abstract][Full Text] [Related]
10. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
[TBL] [Abstract][Full Text] [Related]
11. Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl.
Lu J; Chiang J; Iyer RR; Thompson E; Kaneski CR; Xu DS; Yang C; Chen M; Hodes RJ; Lonser RR; Brady RO; Zhuang Z
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21665-70. PubMed ID: 21098288
[TBL] [Abstract][Full Text] [Related]
12. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
[TBL] [Abstract][Full Text] [Related]
13. Laboratory and genetic evaluation of Gaucher disease.
Bodamer OA; Hung C
Wien Med Wochenschr; 2010 Dec; 160(23-24):600-4. PubMed ID: 20714811
[TBL] [Abstract][Full Text] [Related]
14. Gaucher and Niemann-Pick diseases--enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Mar; 317(1-2):191-7. PubMed ID: 11814475
[TBL] [Abstract][Full Text] [Related]
15. Effective cell and gene therapy in a murine model of Gaucher disease.
Enquist IB; Nilsson E; Ooka A; Månsson JE; Olsson K; Ehinger M; Brady RO; Richter J; Karlsson S
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13819-24. PubMed ID: 16954197
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of lysosomal storage disorders: Gaucher disease.
Johnson BA; Dajnoki A; Bodamer O
Curr Protoc Hum Genet; 2014 Jul; 82():17.15.1-17.15.6. PubMed ID: 25042717
[TBL] [Abstract][Full Text] [Related]
17. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.
Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E
RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808
[TBL] [Abstract][Full Text] [Related]
18. Murine models of acute neuronopathic Gaucher disease.
Enquist IB; Lo Bianco C; Ooka A; Nilsson E; Månsson JE; Ehinger M; Richter J; Brady RO; Kirik D; Karlsson S
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17483-8. PubMed ID: 17954912
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis, biomarkers and biochemical alterations in Gaucher's disease].
Gort L; Coll MJ
Med Clin (Barc); 2011 Sep; 137 Suppl 1():12-6. PubMed ID: 22230120
[TBL] [Abstract][Full Text] [Related]
20. Unfolded protein response in Gaucher disease: from human to Drosophila.
Maor G; Rencus-Lazar S; Filocamo M; Steller H; Segal D; Horowitz M
Orphanet J Rare Dis; 2013 Sep; 8():140. PubMed ID: 24020503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
